NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Qing Zhang
University of Texas Health Science Center at San Antonio - San Antonio / United States
Others
AD Scientific Index ID: 1678397
UT Health San Antonio
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Qing Zhang's MOST POPULAR ARTICLES
1-)
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotypeAA Basiorka, KL McGraw, EA Eksioglu, X Chen, J Johnson, L Zhang, ...Blood, The Journal of the American Society of Hematology 128 (25), 2960-2975, 20162492016
2-)
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control studyNK Gillis, M Ball, Q Zhang, Z Ma, YL Zhao, SJ Yoder, ME Balasis, ...The lancet oncology 18 (1), 112-121, 20172362017
3-)
A multi-institution phase I trial of ruxolitinib in patients with chronic myelomonocytic leukemia (CMML)E Padron, A Dezern, M Andrade-Campos, K Vaddi, P Scherle, Q Zhang, ...Clinical Cancer Research 22 (15), 3746-3754, 2016862016
4-)
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMMLA Yoshimi, ME Balasis, A Vedder, K Feldman, Y Ma, H Zhang, SCW Lee, ...Blood, The Journal of the American Society of Hematology 130 (4), 397-407, 2017882017
5-)
Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosisC Talati, L Zhang, G Shaheen, A Kuykendall, M Ball, Q Zhang, JE Lancet, ...Blood, The Journal of the American Society of Hematology 129 (13), 1881-1883, 2017802017
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept